Nasdaq

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology in Treating Venous Leg Ulcers

Study comparing BioStem’s proprietary amnion chorion allograft versus the standard of care aims to demonstrate superior outcomes, further validating its clinical efficacy to support market expansion ...
Seeking Alpha

Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

HUMACAO, PR and NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Aspire Biopharma Holdings, Inc. (ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery ...
FierceBiotech

Simplifying the Review Process: A Guide to the FDA's Proposed Single IRB Requirement

To comply with the 21st Century Cures Act, 1 the Food and Drug Administration (FDA) has released two Notices of Proposed Rulemaking (NPRMs). NPRMs are the initial public notice of a proposed change to ...
Purdue University

Faculty Update: Migration of Institutional Review Board activities to PERA

Migration of Institutional Review Board (IRB) activities to the Purdue Excellence in Research Administration (PERA) platform is underway. The PERA-IRB module will go live Monday (Oct. 27). With the ...